JP2015521483A5 - - Google Patents

Download PDF

Info

Publication number
JP2015521483A5
JP2015521483A5 JP2015518637A JP2015518637A JP2015521483A5 JP 2015521483 A5 JP2015521483 A5 JP 2015521483A5 JP 2015518637 A JP2015518637 A JP 2015518637A JP 2015518637 A JP2015518637 A JP 2015518637A JP 2015521483 A5 JP2015521483 A5 JP 2015521483A5
Authority
JP
Japan
Prior art keywords
biomarkers
expression
sample
value
normalized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015518637A
Other languages
English (en)
Japanese (ja)
Other versions
JP6366580B2 (ja
JP2015521483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/047354 external-priority patent/WO2013192616A1/en
Publication of JP2015521483A publication Critical patent/JP2015521483A/ja
Publication of JP2015521483A5 publication Critical patent/JP2015521483A5/ja
Application granted granted Critical
Publication of JP6366580B2 publication Critical patent/JP6366580B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015518637A 2012-06-22 2013-06-24 メラニン細胞性病変における分子悪性度 Expired - Fee Related JP6366580B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261663428P 2012-06-22 2012-06-22
US61/663,428 2012-06-22
PCT/US2013/047354 WO2013192616A1 (en) 2012-06-22 2013-06-24 Molecular malignancy in melanocytic lesions

Publications (3)

Publication Number Publication Date
JP2015521483A JP2015521483A (ja) 2015-07-30
JP2015521483A5 true JP2015521483A5 (https=) 2016-07-21
JP6366580B2 JP6366580B2 (ja) 2018-08-01

Family

ID=49769469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015518637A Expired - Fee Related JP6366580B2 (ja) 2012-06-22 2013-06-24 メラニン細胞性病変における分子悪性度

Country Status (7)

Country Link
US (1) US9758829B2 (https=)
EP (1) EP2864500B1 (https=)
JP (1) JP6366580B2 (https=)
CN (1) CN104603291B (https=)
AU (1) AU2013277971B2 (https=)
CA (1) CA2875710C (https=)
WO (1) WO2013192616A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014149629A1 (en) * 2013-03-15 2014-09-25 Htg Molecular Diagnostics, Inc. Subtyping lung cancers
US11021752B2 (en) * 2013-03-15 2021-06-01 Myriad Genetics, Inc. Genes and gene signatures for diagnosis and treatment of melanoma
WO2014182330A1 (en) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Devices and methods for capturing target molecules
JP6496899B2 (ja) * 2014-07-01 2019-04-10 公立大学法人福島県立医科大学 浸潤性髄膜腫判別用試薬、及びその判別方法
EP3164508B1 (en) * 2014-07-02 2023-06-07 Myriad myPath, LLC Genes and gene signatures for diagnosis and treatment of melanoma
EP3218521B1 (en) * 2014-11-12 2019-12-25 Hitachi Chemical Co., Ltd. Method for diagnosing organ injury
WO2016152352A1 (ja) * 2015-03-20 2016-09-29 国立大学法人名古屋大学 メラノーマ特異的バイオマーカー及びその利用
GB2544834A (en) * 2015-06-09 2017-05-31 Waters Technologies Corp Profile diagnositcs in personalized dermatology, dermatopathology and cosmetics
GB2565238A (en) * 2015-06-09 2019-02-06 Waters Technologies Corp Molecular diagnostics in personalized dermatology, dermatopathology and cosmetics
CN107636678B (zh) * 2015-06-29 2021-12-14 北京市商汤科技开发有限公司 用于预测图像样本的属性的方法和设备
DE112016003948T5 (de) 2015-08-31 2018-05-09 City Of Sapporo Molekulare verfahren zum beurteilen einer urothelialen erkrankung
JP7354099B2 (ja) * 2017-10-03 2023-10-02 ジェネシーク ピーティーワイ リミテッド マイクロrna遺伝子発現を使用して黒色腫を診断し、病期分類し、モニタリングする方法
US20210012214A1 (en) * 2018-03-29 2021-01-14 Nec Corporation Learning apparatus, learning method, and computer-readable recording medium
CN108537005B (zh) * 2018-04-03 2019-04-02 福州大学 一种基于BPSO-KNN模型的关键lncRNA预测方法
JP7526100B2 (ja) 2018-05-31 2024-07-31 バークレー ライツ,インコーポレイテッド マイクロ流体デバイスによる微小物体の自動検出及び特徴付け
US11017896B2 (en) * 2018-06-28 2021-05-25 Case Western Reserve University Radiomic features of prostate bi-parametric magnetic resonance imaging (BPMRI) associate with decipher score
FR3085825B1 (fr) 2018-09-14 2021-07-16 Fermentalg Huile de microorganismes riche en acide docosahexaenoique
FR3085962B1 (fr) 2018-09-14 2021-06-18 Fermentalg Procede d'extracton d'une huile riche en pufa
TW202018727A (zh) 2018-11-09 2020-05-16 財團法人工業技術研究院 整體式學習預測方法與系統
CN112513891B (zh) * 2019-01-02 2025-12-05 松下电器(美国)知识产权公司 信息处理装置、信息处理方法及记录介质
CN114693646B (zh) * 2022-03-31 2023-04-11 中山大学中山眼科中心 一种基于深度学习的角膜内皮细胞活性因子的分析方法
JP7806660B2 (ja) * 2022-11-11 2026-01-27 コニカミノルタ株式会社 検出方法
WO2024108191A1 (en) * 2022-11-18 2024-05-23 University Of Virginia Patent Foundation Machine learning approach to predicting lymph node metastases
CN117625632A (zh) * 2024-01-22 2024-03-01 中国医学科学院北京协和医院 肌萎缩侧索硬化症的SQSTM1的p.L382CfsTer13突变致病基因及其应用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
WO1985001051A1 (en) 1983-09-02 1985-03-14 Molecular Biosystems, Inc. Oligonucleotide polymeric support system
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5219727A (en) 1989-08-21 1993-06-15 Hoffmann-Laroche Inc. Quantitation of nucleic acids using the polymerase chain reaction
US5554501A (en) 1992-10-29 1996-09-10 Beckman Instruments, Inc. Biopolymer synthesis using surface activated biaxially oriented polypropylene
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
EP0758403B1 (en) 1994-05-05 1998-06-24 Beckman Instruments, Inc. Oligonucleotide repeat arrays
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5736330A (en) 1995-10-11 1998-04-07 Luminex Corporation Method and compositions for flow cytometric determination of DNA sequences
US5716784A (en) 1996-02-05 1998-02-10 The Perkin-Elmer Corporation Fluorescence detection assay for homogeneous PCR hybridization systems
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US5985567A (en) 1997-08-15 1999-11-16 Beckman Coulter, Inc. Hybridization detection by pretreating bound single-stranded probes
US20030096232A1 (en) 1997-12-19 2003-05-22 Kris Richard M. High throughput assay system
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6238869B1 (en) 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6458533B1 (en) 1997-12-19 2002-10-01 High Throughput Genomics, Inc. High throughput assay system for monitoring ESTs
US6013789A (en) 1998-02-20 2000-01-11 Beckman Coulter, Inc. Covalent attachment of biomolecules to derivatized polypropylene supports
AU2375600A (en) 1998-12-22 2000-07-12 Stephen Felder High throughput assay system using mass spectrometry
WO2000066265A2 (en) 1999-04-27 2000-11-09 Ciphergen Biosystems, Inc. Probes for a gas phase ion spectrometer
EP1410011B1 (en) 2001-06-18 2011-03-23 Rosetta Inpharmatics LLC Diagnosis and prognosis of breast cancer patients
US7171311B2 (en) 2001-06-18 2007-01-30 Rosetta Inpharmatics Llc Methods of assigning treatment to breast cancer patients
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
JP2007527247A (ja) 2004-03-05 2007-09-27 ロゼッタ インファーマティクス エルエルシー 臨床的基準および情報提供性遺伝子セットの組合せを使用する乳癌患者の分類
BRPI0512587A (pt) 2004-06-25 2007-09-18 Veridex Llc processo e reagentes para detecção de melanoma
CN101687022B (zh) 2007-03-26 2016-09-07 莱顿大学医学中心附属莱顿教学医院 Prame衍生的肽以及包括该肽的免疫原组合物
US20080268451A1 (en) 2007-03-30 2008-10-30 Bruce Seligmann Measurement of an insoluble analyte in a sample
WO2009062199A1 (en) 2007-11-09 2009-05-14 Fox Chase Cancer Center EGFR/NEDD9/TGF-β LNTERACTOME AND METHODS OF USE THEREOF FOR THE IDENTIFICATION OF AGENTS HAVING EFFICACY IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
WO2009099905A2 (en) * 2008-02-01 2009-08-13 Memorial Health Inc. Molecular signatures and biomarkers associated with melanoma and methods of use thereof
CN102089444A (zh) 2008-05-14 2011-06-08 德玛泰克国际公司 利用核酸分析方法来诊断黑素瘤和太阳能雀斑
US20120041274A1 (en) 2010-01-07 2012-02-16 Myriad Genetics, Incorporated Cancer biomarkers
EP3812469A1 (en) 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
WO2012031008A2 (en) * 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2619332A4 (en) 2010-09-22 2014-04-16 Dave S B Hoon DIRECT BLOOD ASSAY TO DETECT MICROARN CIRCULATING IN PATIENTS WITH CANCER
ES2597032T3 (es) 2011-05-04 2017-01-13 HTG Molecular Diagnostics, Inc Mejoras en un ensayo cuantitativo de protección contra la nucleasa (qNPA) y secuenciación (qNPS)
AU2012316129B2 (en) 2011-09-28 2017-10-05 Htg Molecular Diagnostics, Inc. Methods of co-detecting mRNA and small non-coding RNA

Similar Documents

Publication Publication Date Title
JP2015521483A5 (https=)
US11111541B2 (en) Diagnostic MiRNA markers for Parkinson's disease
JP2012525147A5 (https=)
Trilles et al. Identification of the major molecular types of Cryptococcus neoformans and C. gattii by hyperbranched rolling circle amplification
JP2017525371A5 (https=)
JP2014533949A5 (https=)
JP2016509833A5 (https=)
US10457988B2 (en) MiRNAs as diagnostic markers
Trick et al. High resolution estimates of relative gene abundance with quantitative ratiometric regression PCR (qRR-PCR)
WO2015155517A1 (en) Molecular predictors of sepsis
WO2017160779A3 (en) Methods and kits to identify klebsiella strains
CN106661623A (zh) 使用miRNA生物标志物相对于多发性硬化诊断视神经脊髓炎
JP2010035532A (ja) アレル特異的pcr法
US10036069B2 (en) Biomarkers for assessing idiopathic pulmonary fibrosis
KR20170124014A (ko) 피부 민감도의 예측 방법
Fan et al. Novel polymorphic multilocus microsatellite markers to distinguish Candida tropicalis isolates
KR101335483B1 (ko) 인유두종바이러스 검출 및 유전형 확인 방법
Hansen et al. SNP-based differentiation of Phytophthora infestans clonal lineages using locked nucleic acid probes and high-resolution melt analysis
RU2684314C2 (ru) Способ выявления микобактерий туберкулеза генотипа Beijing В0-кластер в формате реального времени
US10227655B2 (en) Method for analyzing body fluid samples
JP2020178555A (ja) 緑内障のリスクを判定する方法
Jang et al. Multiplex genotyping of cytokine gene SNPs using fluorescence bead array
WO2022023317A1 (en) Use of circular rna for the diagnosis of multiple sclerosis
Mercer Newborn screening for spinal muscular atrophy
Pereira et al. Impact of DNA polymerase choice on assessment of bacterial communities by a Legionella genus-specific next-generation sequencing approach